Ospedale San Raffaele
hsr.itTotal trials
46
Active
10
Phase 3
5
Total enrollment
48,202
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| genetic polymorphisms | — | — | — | — | — | 1 |
Next readouts
- 2040-05-19
Top conditions
- Type 1 Diabetes3
- Hypertension3
- Respiratory Failure3
- Postpancreatectomy Hyperglycemia2
- Motor Neuron Disease2
- Diabetes2
- Mitral Regurgitation2
- Genetic Hypertension2
Frequently asked questions about Ospedale San Raffaele
- How many clinical trials does Ospedale San Raffaele have on ClinicalTrials.gov?
- Ospedale San Raffaele is listed as the lead sponsor on 46 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ospedale San Raffaele's trials are in Phase 3?
- 5 of Ospedale San Raffaele's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Ospedale San Raffaele focus on?
- Ospedale San Raffaele's most-studied conditions on ClinicalTrials.gov are Type 1 Diabetes, Hypertension, Respiratory Failure, Postpancreatectomy Hyperglycemia, Motor Neuron Disease.
- When are Ospedale San Raffaele's next clinical trial readouts?
- Ospedale San Raffaele has 1 upcoming primary-completion readout tracked here; the soonest is “Genetics in the Progression of Nephropathies”, expected around 2040-05-19.